SCHEMBL1948103

SCHEMBL1948103

O=CB(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL31447465 0.80
Boric Acid SCHEMBL27950779 0.67
Boric Acid SCHEMBL9147677 0.67
Boric Acid SCHEMBL11126143 0.63
Boric Acid SCHEMBL30489344 0.63
Boric Acid SCHEMBL78758 0.63
Boric Acid SCHEMBL11330199 0.63
Formic Acid SCHEMBL11420267 0.63
Methane Boronic Acid SCHEMBL935322 0.60
SCHEMBL29039658 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023239925-A1 CYCLOPHILIN INHIBITORS AND USES THEREOF THE BROAD INSTITUTE, INC. (US) 2023-12-14 WO disclosed
EP-2536276-B1 NOVEL BEXAROTENE ANALOGS UNIV ARIZONA (US) 2016-11-23 EP disclosed
US-9174917-B2 Bexarotene analogs ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2015-11-03 US disclosed
EP-2536276-A1 NOVEL BEXAROTENE ANALOGS The Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University (US) 2012-12-26 EP disclosed
US-20120309833-A1 NOVEL BEXAROTENE ANALOGS ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY 2012-12-06 US disclosed
WO-2011103321-A1 NOVEL BEXAROTENE ANALOGS ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2011-08-25 WO disclosed
US-20110136877-A1 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS LIGAND PHARMACEUTICALS INC. (US) 2011-06-09 US disclosed
EP-2240434-A1 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS Ligand Pharmaceuticals Inc. (US) 2010-10-20 EP disclosed
WO-2009089192-A1 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS LIGAND PHARMACEUTICALS INC. (US) 2009-07-16 WO disclosed
EP-1148876-A4 CALCILYTIC COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2003-07-23 EP disclosed
US-6417215-B1 USE AS CALCIUM RECEPTOR ANTAGONISTS. EXTRACELLULAR CA.SUP.2+ INHIBITS THE SECRETION OF PARATHYROID HORMONE (?PTH?) FROM PARATHYROID CELLS, SMITHKLINE BEECHAM CORPORATION 2002-07-09 US disclosed
EP-1148876-A1 CALCILYTIC COMPOUNDS SmithKline Beecham Corporation (US) 2001-10-31 EP disclosed
WO-2000045816-A1 CALCILYTIC COMPOUNDS SMITHKLINE BEECHAM CORPORATION (GB) 2000-08-10 WO disclosed
US-5948696-A LIBRARY OF COMPOUNDS LINKED TO SOLID SUPPORT; SUPPORT ALSO HAS IDENTIFIER MOLECULE (TAG); FOR USE IN SCREENING BIOLOGICALLY ACTIVE MOLECULES SUCH AS ENZYME INHIBITORS PHARMACOPEIA, INC. (US) 1999-09-07 US disclosed